Evidence map›Paper›PMID 33241167›Full record

ArticleTranslational medicine of aging2019

Computational tools for geroscience.

Joseph C P Kruempel, Marshall B Howington, Scott F Leiser

Abstract read
In one paragraph

Article in Translational medicine of aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph C P KruempelMolecular & Integrative Physiology Department, University of Michigan, Ann Arbor, MI, 48109, USA.
Marshall B HowingtonCellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, 48109, USA.
Scott F LeiserMolecular & Integrative Physiology Department, University of Michigan, Ann Arbor, MI, 48109, USA.

Funding

CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Mechanisms of cell non-autonomous signaling through the hypoxic responseR01AG058717 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEISER, SCOTT F · 2019 to 2023
$1.6M
Novel approaches to study emerging roles of xenobiotic enzymesR21AG059117 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEISER, SCOTT F · 2018 to 2019
$429k
NIA NIH HHS R01 AG058717NIA NIH HHS R21 AG059117NIGMS NIH HHS T32 GM007315
6 · The paper itself

Abstract

The rapid progress of the past three decades has led the geroscience field near a point where human interventions in aging are plausible. Advances across scientific areas, such as high throughput "-omics" approaches, have led to an exponentially increasing quantity of data available for biogerontologists. To best translate the lifespan and healthspan extending interventions discovered by basic scientists into preventative medicine, it is imperative that the current data are comprehensively utilized to generate testable hypotheses about translational interventions. Building a translational pipeline for geroscience will require both systematic efforts to identify interventions that extend healthspan across taxa and diagnostics that can identify patients who may benefit from interventions prior to the onset of an age-related morbidity. Databases and computational tools that organize and analyze both the wealth of information available on basic biogerontology research and clinical data on aging populations will be critical in developing such a pipeline. Here, we review the current landscape of databases and computational resources available for translational aging research. We discuss key platforms and tools available for aging research, with a focus on how each tool can be used in concert with hypothesis driven experiments to move closer to human interventions in aging.

Indexed as

BiogerontologyBioinformaticsDatabasesGerosciencePreventative medicine

Identifiers

PMID33241167
PMCPMC7685266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.